Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
5.60
+0.23 (4.28%)
Apr 25, 2025, 12:43 PM EDT - Market open

Emergent BioSolutions Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Market Capitalization
3045181255892,3394,749
Upgrade
Market Cap Growth
315.99%315.99%-78.86%-74.81%-50.75%70.50%
Upgrade
Enterprise Value
8681,0449171,4142,8245,255
Upgrade
Last Close Price
5.379.562.4011.8143.4789.60
Upgrade
PE Ratio
----10.6515.53
Upgrade
Forward PE
81.1712.57-51.157.199.53
Upgrade
PS Ratio
0.270.500.120.531.323.01
Upgrade
PB Ratio
0.601.070.190.431.453.28
Upgrade
P/TBV Ratio
--1.511.342.999.18
Upgrade
P/FCF Ratio
8.1514.47--24.3412.02
Upgrade
P/OCF Ratio
4.978.82--7.308.85
Upgrade
PEG Ratio
---11.760.210.68
Upgrade
EV/Sales Ratio
0.831.000.871.261.593.33
Upgrade
EV/EBITDA Ratio
16.2619.55-90.085.608.63
Upgrade
EV/EBIT Ratio
----7.3210.53
Upgrade
EV/FCF Ratio
24.2629.17--29.3913.30
Upgrade
Debt / Equity Ratio
1.401.401.351.030.540.64
Upgrade
Debt / EBITDA Ratio
12.6612.66-90.851.721.50
Upgrade
Debt / FCF Ratio
18.8918.89--9.132.34
Upgrade
Asset Turnover
0.650.650.420.370.610.61
Upgrade
Inventory Turnover
2.092.092.031.853.012.70
Upgrade
Quick Ratio
1.561.560.470.662.292.22
Upgrade
Current Ratio
3.693.691.040.993.403.11
Upgrade
Return on Equity (ROE)
-33.67%-33.67%-74.67%-14.11%14.35%24.12%
Upgrade
Return on Assets (ROA)
-2.03%-2.03%-4.21%-2.23%8.26%11.98%
Upgrade
Return on Capital (ROIC)
-2.43%-2.43%-4.84%-2.58%9.93%14.52%
Upgrade
Return on Capital Employed (ROCE)
----14.90%20.00%
Upgrade
Earnings Yield
-65.32%-36.80%-610.73%-35.91%9.39%6.44%
Upgrade
FCF Yield
12.27%6.91%-207.11%-25.44%4.11%8.32%
Upgrade
Buyback Yield / Dilution
-3.52%-3.52%-2.20%7.39%-0.56%-2.67%
Upgrade
Updated Mar 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q